Comparison of SASSONE Scoring and ADNEX Model in Differentiating Benign and Malignant Ovarian Neoplasm in a University Hospital

Romina Grizelda O. Mallari, Maria Lourdes B. Coloma

Apr 2018 DOI 10.35460/2546-1621.2017-0072     Access   

Abstract

Background: Ovarian cancer is the second most common gynecologic cancer worldwide and are usually diagnosed in advanced stages where prognosis is very poor. Ultrasound has been widely used to screen and differentiate benign and malignant ovarian neoplasm. There are several ultrasound scoring system designed to aid in the diagnosis, however, there is still no standard method accepted for screening of ovarian cancer.

Objective: To compare the accuracy of SASSONE Scoring and ADNEX Model in differentiating benign and malignant ovarian neoplasm in the University of Santo Tomas Hospital.

Methodology: Sixty-eight women who presented with an ovarian neoplasm by history and physical examination were recruited from January to October 2017. Ultrasound was requested to further characterize the mass.

Sassone scoring and ADNEX Model were applied and computed based on the sonologic findings to differentiate whether the ovarian neoplasm was benign or malignant. The gold standard was the histopathologic examination of the mass after surgery.

Results: There was no significant difference in the accuracy of Sassone Scoring and ADNEX model in pre-operatively differentiating benign and malignant ovarian neoplasm with 88% and 89% accuracy rate, respectively. Sassone scoring has a sensitivity of 62.5% and specificity of 91.67% while ADNEX has a sensitivity and  specificity of 37.5% and 96.67%, respectively.

Conclusion: There is no significant difference in using SASSONE and ADNEX model in differentiating benign and malignant ovarian neoplasm prior to surgery. Both may be used as an ultrasound scoring system for predicting ovarian malignancy. However, in cases of suspicious tumors, ADNEX model is more useful in discriminating the type and stage of malignancy.

  1. Shende V, Kamat A, Raut S, et. al. Sassone Scoring System in Differentiating Benign and Malignant Adnexal Masses. Indian Journal of Applied Research; 2016. Vol 6, No 3.
  2. Calster BV,  Hoorde KV, Valentin L,  et al. Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicenter diagnositic study. BMJ 2014; 349: g5920 doi: 10.1136/bmj.g5920
  3. Redaniel MT, Laudico A, Mirasol-Lumague MR, et al. Ovarian cancer survival population differences: a “high resolution study” comparing Philippine residents, and Filipino-Americans and Caucasians living in the US. 2009. 9:340
  4. Tien Le, Christopher Giede. Initial Evaluation and Referral Guidelines for Management of Pelvic/Ovarian Masses. Joint SOGC/GOC/SCC Clinical Practice Guidelines. No. 230, July 2009.
  5. Dias DS, Bueloni-Dias FN, Demanto A, et al. Clinical management of incidental findings on pelvic adnexal masses. Faculdade de Medicina de Botucatu, Universidead Estadual Paulista Julio, Brazil. REV ASSOC MED BRAS 2015; 61(5):469-473
  6. Buderer NM. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Academic Emergency Medicine; 1996. 3(9).
  7. Altman DG, Machin D, Bryant TN, Gardner MJ (Eds) (2000) Statistics with confidence, 2nd ed. BMJ Books. MedCal, 2016.
  8. Van Calster, B, Van Hoorde K, Froyman W, et al. 2015. Practical guidance for applying the ADNEX model from the IOTA group to discriminate between different subtypes of adnexal tumors. Facts Views Vis OBGYN, 2015, 7 (1): 32-41
  9. Abramowicz JS, Timmerman Dirk.  2017 Ovarian mass-differentiating benign from malignant: the value of the International Ovarian Tumor Analysis ultrasound rules. American Journal of Obstetrics and Gynecology. 2017 Jul 20. pii: S0002-9378(17)30861-X. doi: 10.1016/j.ajog.2017.07.019
  10. Santosh Kumar Dora, Atal Bihari Dandapat, Benudhar Pande and Jatindra Prasad Hota. A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass. Department of Obstetrics and Gynecology, Veer Surendra Sai Institute of Medical Science and Research (VIMSAR), Burla, India. Journal of Ovarian Research (2017) 10:55

Articles related to the one you are viewing

There are currently no results to show, please try again later

CC BY: Open Access Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/